CeloNova BioSciences, Inc. products

CeloNova develops and manufactures novel surface coated technologies including its proprietary Polyzene-F nanocoating and COBRA SG Drug-Coated PTCA Balloon technology. This next-generation innovation is transforming clinical practice and promoting positive outcomes in patients around the world.

COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.

Our proprietary COBRA SG drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery. Developed at a leading, international medical university, the novel coating enables a unique and efficient excipient to carry a non-proliferative drug on the surface of PTCA balloons and has the flexibility to be modified to accommodate a number of clinical applications.